Galmed pharmaceuticals ltd.

Major-Pharmaceuticals

GLMD


16 Tiomkin Street
Tel Aviv , 6578317

Executive/
Director

Price

  • Last Close
  • $ 3.39
    $ +0.07 2.11 %
    Jan 3, 2025
  • 52-Week High/Low
  • $0.87 - $0.26
  • YTD
  • 9%

  • Trading Volume
  • 2,257
  • Market Cap Full
  • $ 85.4M
  • Shares Outstanding
  • 25.2M
    Dec 31, 2022
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 -35.2% 39.3% -39.1% 19.6% -5% 8% -12.6% -14.6% -29% 9%
Q2 -8.9% 26.8% 136.1% -15% 4% -9.5% -59.1% 581.5% 16.7% -
Q3 -1.1% 47.4% 15.2% -33.4% 8% -8.2% -52.2% -78.7% -12.9% -
Q4 -21% 1.4% -50.2% 24.1% -11.9% -34.8% 60.8% -14.2% 0.3% -
J F M A M J J A S O N D
2025 9% - - - - - - - - - - -
2024 -18% 6.7% -18.8% 14.9% - - - -12.9% - - - 8%
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    31%-54%161%-25%-14%-47%-41%-73%-9%584%9%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.36 0.26 -0.17 -0.17 -0.29 -0.38 -0.24 -1.09
Q2 0.39 0.22 -0.17 -0.2 -0.26 -0.33 -0.15 -0.95
Q3 0.34 0.23 -0.05 -0.21 -0.32 -0.31 -0.21 -0.24
Q4 0.40 0.27 -0.15 -0.39 -0.48 -0.3 -1.65 -
A 1.5 1 -0.5 -1 -1.35 -1.3 -0.7 -2.28

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022
Mar - - - - -
Jun 20.9 - - - -
Sep - - - - -
Dec 21 21.1 21.3 25.1 25.2

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage - 33 30 11 11
Equity multiplier 0.2 - - - -